David Vaughan
Corporate Officer/Principal bei ANTIBE THERAPEUTICS INC.
Vermögen: 3 784 $ am 30.04.2024
Profil
David Vaughan is the founder of Talon Pharmaceutical Services, Inc. He currently holds the position of Chief Development Officer at Antibe Therapeutics, Inc. and Antibe Holdings, Inc. His former positions include Head-Anti Infectives at Bayer, Inc., Vice President-Pharmaceutical Business Unit at Quest Diagnostics Infectious Disease, Inc., Vice President-Preclinical Development at Affinium Pharmaceuticals Ltd., and Vice President-Preclinical Development at NeurAxon, Inc. He holds a doctorate degree from the University of Toronto.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
04.03.2024 | 26 662 ( 0,05% ) | 3 784 $ | 30.04.2024 |
Aktive Positionen von David Vaughan
Unternehmen | Position | Beginn |
---|---|---|
ANTIBE THERAPEUTICS INC. | Corporate Officer/Principal | 01.11.2012 |
Antibe Holdings, Inc.
Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Corporate Officer/Principal | 01.01.2007 |
Talon Pharmaceutical Services, Inc.
Talon Pharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Talon Pharmaceutical Services, Inc. provides Pharmaceutical services. The company was founded by Shawn Maddaford and David Vaughan and is headquartered in Mississauga, CA. | Gründer | - |
Ehemalige bekannte Positionen von David Vaughan
Unternehmen | Position | Ende |
---|---|---|
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Corporate Officer/Principal | - |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA. | Corporate Officer/Principal | - |
Affinium Pharmaceuticals Ltd.
Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Corporate Officer/Principal | - |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Corporate Officer/Principal | - |
Ausbildung von David Vaughan
University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ANTIBE THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Antibe Holdings, Inc.
Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Finance |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Process Industries |
Talon Pharmaceutical Services, Inc.
Talon Pharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Talon Pharmaceutical Services, Inc. provides Pharmaceutical services. The company was founded by Shawn Maddaford and David Vaughan and is headquartered in Mississauga, CA. | Health Technology |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA. | Commercial Services |
Affinium Pharmaceuticals Ltd.
Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |